Frontiers in Cardiovascular Medicine

JULY 14, 2024

Atrial fibrillation (AF) significantly increases the risk of stroke and heart failure, but is frequently asymptomatic and intermittent; therefore, its timely diagnosis poses challenges. Despite their promise, the evolving landscape of AI-enabled smartwatch-based AF detection raises questions about the clinical value of this technology.

Atrial Fibrillation 98

Atrial Fibrillation Heart Failure Technology Patient Care 98

Medical Xpress - Cardiology

JULY 8, 2024

Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF), according to the largest study of its kind on this new technology, led by the Icahn School of Medicine at Mount Sinai.

Atrial Fibrillation 80

Atrial Fibrillation Ablation Technology 80

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. Circulation.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

The New England Journal of Medicine

JANUARY 24, 2024

This article reviews the use of digital wearable technologies for monitoring of three common cardiovascular conditions: hypertension, heart failure, and atrial fibrillation.

Technology 72

Technology Atrial Fibrillation Article Heart Failure 72

Science Daily - Heart Disease

APRIL 22, 2024

Atrial fibrillation is the most common cardiac arrhythmia worldwide with around 59 million people concerned in 2019. Researchers have recently developed a deep-learning model capable of predicting the transition from a normal cardiac rhythm to atrial fibrillation.

Arrhythmia 121

Arrhythmia Atrial Fibrillation Dementia Heart Failure 121

DAIC

MARCH 28, 2025

28, 2025 At theAmerican College of Cardiology (ACC) 2025 meeting,GE HealthCare will introduce RevolutionVibe, i a new computed tomography (CT) system with Unlimited One-Beat Cardiac imaging to deliver consistent, high-quality images for patients, even in challenging cases like atrial fibrillation and heavily calcified coronaries.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

DAIC

JULY 16, 2024

mtaschetta-millane Tue, 07/16/2024 - 09:47 July 16, 2024 — Ultrahuman, a pioneer in wearable technology , launches PowerPlugs, a platform for individual apps and plugins built on top of Ultrahuman’s health and wellness data stack. This is the world’s first in a smart ring form factor.

AFIB 105

AFIB Technology Heart Rhythm Arrhythmia 105

HeartRhythm

AUGUST 31, 2024

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Smart technologies such as smartphones and smartwatches used in everyday life offer promising avenues for enhancing AF management.

Atrial Fibrillation 40

Atrial Fibrillation Technology Heart Rhythm Arrhythmia 40

DAIC

FEBRUARY 12, 2025

cardiac electrophysiologist, performed one of the nations first procedures to control atrial fibrillation (Afib) using a new type of catheter that can deliver two different types of electrical energy or ablation to destroy the damaged part of the heart that is triggering the abnormal heartbeats. 12, 2025 On Feb.

AFIB 52

AFIB Research Ablation Atrial Fibrillation 52

HeartRhythm

MARCH 28, 2025

Rhythm control therapy and especially atrial fibrillation (AF) ablation are the focus of growing research in patients with AF. Novel technologies such as pulsed field ablation (PFA) may improve the safety and efficacy of AF ablation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Quality of Life Technology 40

DAIC

FEBRUARY 12, 2024

milla1cf Mon, 02/12/2024 - 15:18 February 12, 2024 — BIOTRONIK , a leader in implantable medical device technology, announced today they will solely supply their proprietary DX models for new single-chamber ICD implants moving forward. For more information: [link] References: Thomas G, Choi DY, Doppalapudi H, et al. January CT, et al.

Technology 64

Technology Atrial Fibrillation Defibrillator Sudden Cardiac Death 64

DAIC

MARCH 31, 2025

tim.hodson Mon, 03/31/2025 - 15:02 March 31, 2025 iRhythm Technologies, Inc. AF Often Asymptomatic: Even for atrial fibrillation (AF)the most commonly symptomatic arrhythmiaover half of all cases were asymptomatic. Its estimated that undiagnosed atrial fibrillation alone costs the U.S. $3 2016;11(8).

Arrhythmia 52

Arrhythmia Atrial Fibrillation Tachycardia Heart Failure 52

DAIC

JANUARY 29, 2025

16, 2025 Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable cardiac monitors (ICM), paired with a novel algorithm, were able to detect atrial fibrillation episodes and properly risk stratify patients as high risk prior to an AF-related healthcare utilization 80% of the time. 2024, May 15).

AFIB 52

AFIB Atrial Fibrillation Quality of Life Heart Rhythm 52

MIBHS

JANUARY 31, 2025

In the age of technology, wearable devices have revolutionized how we approach health and wellness. This blog explores the ways wearable technology can help track heart health, the advantages it offers, and how it contributes to better outcomes for those requiring surgical intervention.

Heart Rhythm 52

Heart Rhythm Technology AFIB Exercise 52

DAIC

MAY 3, 2024

Clinical trials and innovative technology took center stage during the month of April, racking up some record number views. New Study Reveals 65 and Older Population Lowered Blood Pressure, Cholesterol and Weight Using Mobile Technology 2. Shorten the Blanking Period After Atrial Fibrillation Ablation, Experts Say 4.

Blood Pressure 105

Blood Pressure Angioplasty Heart Attack Heart attacks 105

HeartRhythm

JULY 21, 2024

The global health challenge posed by cardiac arrhythmias, particularly atrial fibrillation (AF), is significant, with heightened risks of stroke, heart failure, and systemic embolism1. Traditional arrhythmia detection has often missed transient or asymptomatic episodes, relying on symptomatic presentations and episodic monitoring.

Technology 45

Technology Arrhythmia Atrial Fibrillation Heart Failure 45

DAIC

SEPTEMBER 11, 2024

million Americans have atrial fibrillation. Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 tim.hodson Wed, 09/11/2024 - 15:40 Sept. million U.S. million U.S.

Atrial Fibrillation 92

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 92

DAIC

JUNE 4, 2024

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment 5. Late-breaking Clinical Trial Results from FARADISE, admIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment 8.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Peripheral Arterial Disease Heart Failure Atrial Fibrillation 105

DAIC

MARCH 27, 2025

tim.hodson Thu, 03/27/2025 - 12:18 March 27, 2025 Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib). The One System Solution provided by EnSite X can accommodate all EP procedures and compatible technologies. 1 Fact Sheets for Press.

Ablation 52

Ablation AFIB Atrial Fibrillation Electrophysiology 52

Frontiers in Cardiovascular Medicine

MAY 1, 2024

BackgroundCatheter ablation is frequently used to manage recurrent atrial fibrillation (AF) resistant to drug therapy, with pulmonary vein isolation (PVI) as a key tactic. The reconnection of pulmonary veins was discovered primarily in the anterior region of the right superior PV and the superior portion of the left superior PV.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Pulmonary Technology 52

HeartRhythm

MARCH 12, 2024

We are diagnosing atrial fibrillation (AF) more often that at any time in history. This is driven by the aging of our populations, the growing prevalence of AF risk factors and by the proliferation of longer-term electrocardiographic monitoring, including patient-facing technologies 1,2.

Atrial Fibrillation 45

Atrial Fibrillation Stroke Strokes Risk Factors 45

HeartRhythm

SEPTEMBER 23, 2024

Atrial fibrillation (AF) is the most common arrhythmia worldwide, with increasing prevalence resulting from improved awareness, increased life expectancy, and advances in detection technology.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Rhythm Electrophysiology 40

Nature Reviews - Cardiology

JUNE 24, 2024

Nature Reviews Cardiology, Published online: 25 June 2024; doi:10.1038/s41569-024-01053-7 The advent of pulsed-field ablation — a series of ultra-rapid, high-energy pulses that result in non-thermal cell death via electroporation — is revolutionizing the field of atrial fibrillation ablation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology 40

HeartRhythm

APRIL 30, 2024

The absence of TAR has hindered successful LAT mapping during atrial fibrillation (AF). TARLess, a novel technology enabling LAT mapping without TAR, shows promise for advancing AF activation mapping.

Atrial Fibrillation 40

Atrial Fibrillation Technology 40

DAIC

FEBRUARY 2, 2024

Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation [abstract].

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

HeartRhythm

APRIL 30, 2024

Omnipolar technology near-field (OTNF) is an emerging cardiac mapping approach and may provide insights into electroanatomical substrate mapping during atrial fibrillation (AF) ablation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology 40

HeartRhythm

AUGUST 21, 2024

No data have been reported on cooling characteristics and the impact of variant pulmonary vein (PV) anatomy on atrial fibrillation (AF) recurrences after POLARx cryoballoon (CB) ablation.

Anatomy 40

Anatomy Atrial Fibrillation Pulmonary Ablation 40

DAIC

OCTOBER 30, 2024

30, 2024 — HeartLung Technologies , a developer of AI tools for early detection of heart disease, lung cancer and other conditions announced that its AI-enabled Automated Cardiac Chambers Volumetry (AutoChamber) recently received “Breakthrough Medical Device” designation and marketing authorization from the U.S. “By

Cancer 45

Cancer Atrial Fibrillation Sudden Cardiac Death Heart Failure 45

Journal of Cardiovascular Electrophysiology

MARCH 19, 2025

ABSTRACT Introduction Pulmonary vein isolation (PVI) using a cryoballoon is well-established for the treatment of paroxysmal atrial fibrillation (PAF). Compared to other available technologies, the usage of a stable, low-pressure cryoballoon (POLARx, Boston Scientific) has demonstrated lower nadir temperatures and longer thawing times.

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Pulmonary Technology 40

DAIC

FEBRUARY 27, 2024

Bernard's Heart & Vascular Center , Jonesboro, Arkansas) mark a significant milestone in the pursuit of innovative solutions for non-valvular atrial fibrillation (NVAF) treatment. It's exciting to be part of the evolution of the latest technology into a tangible solution for treating patients.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

Stroke Journal

NOVEMBER 21, 2023

Atrial fibrillation is a major cause of ischemic stroke. Technological advances now support prolonged cardiac rhythm monitoring using either surface electrodes or insertable cardiac monitors. Furthermore, the clinical significance of very short duration paroxysmal atrial fibrillation remains controversial.

Atrial Fibrillation 40

Atrial Fibrillation Stroke Strokes Technology 40

Journal of Cardiovascular Electrophysiology

OCTOBER 3, 2024

Abstract Introduction Atrial fibrillation (Afib) is a prevalent chronic arrhythmia associated with severe complications, including stroke, heart failure, and increased mortality. Despite ethical considerations and disparities, the potential benefits outweigh the challenges.

Atrial Fibrillation 40

Atrial Fibrillation AFIB Technology Heart Failure 40

HeartRhythm

SEPTEMBER 9, 2024

Pulsed field ablation (PFA) for the treatment of paroxysmal atrial fibrillation (AF) was validated to be safe and effective.1 Widespread adoption of this potentially transformative technology has brought into the focus the economics of AF with new therapies requiring significant capital and disposable investment.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology 40

DAIC

JULY 17, 2024

The present invention relates to medical methods for transseptal access to the heart using steerable introducers based on the Company’s Morph DNA technology. This additional patent protection for BioCardia’s current and future products in this important existing market enhances shareholder value.

Myocardial Infarction 105

Myocardial Infarction Atrial Fibrillation Technology Angina 105

Frontiers in Cardiovascular Medicine

DECEMBER 19, 2023

Background The rising adoption of wearable technology increases the potential to identify arrhythmias. Herein, we report results of a follow-up screening protocol for incident atrial fibrillation/flutter (AF) within a large observational digital health study.

Blood Pressure 64

Blood Pressure Atrial Fibrillation AFIB Arrhythmia 64